Atlas Trials

A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

Clinical trial NCT01511432 · COMPLETED

Trial details

NCT number
NCT01511432
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2012-01-01
Primary completion
2012-06-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.